Journal of intravenous nursing : the official publication of the Intravenous Nurses Society
-
Care coordination and development of a plan to track vascular access devices (VADs) is presented. The article discusses how to establish criteria so that central venous catheters can be monitored. Specific areas of focus for monitoring outcomes are reviewed, as is the process of obtaining invaluable information. This information can be used to support policy and procedure changes and clinical practice changes to provide quality outcomes.
-
The role of the interventional radiologist in the care of patients requiring placement of central venous access devices is rapidly evolving. With experience gained from diagnosing and treating central venous catheter-related complications, interventional radiologists are assuming an increasing role in the placement of these devices. With imaging guidance, catheter and guidewire skills, and a commitment to providing a clinical service that includes management of catheter malfunctions and complications, central venous access by the interventional radiologist has proven a safe and effective alternative to standard surgical techniques.
-
Based on patient condition, intravenous therapies, caregiver support, and organizational policy, correct device selection plays an integral part in the overall care and management of the alternate care setting i.v. therapy patient. This paper will identify the various aspects of appropriate device selection for i.v. therapy prescriptions.
-
Experience and comfort with central venous access devices (CVADs) has increased dramatically during the past 2 decades. However, coordination of care remains a challenge as patients with long-term catheters move between levels of care with multiple healthcare providers. ⋯ Effective communication among all care providers enhances teamwork and improves efficiency. The consistent collection and evaluation of data regarding CVAD complications and outcomes is important for assessing quality and determining best practices.
-
Pain management is rapidly changing as the mysteries of how healthy and damaged nervous systems work to communicate pain to the brain become better understood. The role of subcutaneous or intravenous lidocaine in the management of neuropathic pain has been increasingly studied. Patients with a variety of pain have been shown to benefit from this therapy, including patients with cancer, postherpetic neuralgia, second degree burns, strokes, and diabetes. As research and experience grow, so too will the practitioner's ability to successfully use intravenous and subcutaneous lidocaine therapy for their patients with pain.